I'm happy to report that no fighters competing at the UFC 162: "Silva vs. Weidman" pay-per-view (PPV) event, which took place last Saturday night (July 6, 2013) at the MGM Grand Garden Arena in Las Vegas, Nevada, were using or abusing testosterone replacement therapy (TRT).
These days, fighters not taking TRT seems to be news, rather than the other way around.
But there was, however, one therapeutic use exemption (TUE) issued by the Nevada State Athletic Commission (NSAC). That honor went to middleweight veteran Chris Leben, who was granted a pass for the prescription opioid medication Suboxone.
NSAC Executive Director Keith Kizer alerted MMAmania.com to the TUE earlier today.
Suboxone is typically used to help recovering addicts overcome an opiate dependency. Leben was suspended for one year following a failed drug test in the wake of his technical knockout loss (cut) to Mark Munoz at the UFC 138 event in Birmingham, England, back in 2011.
"The Crippler" tested positive for Oxycodone and Oxymorphine, two prescription painkillers.
Sine then, the former "Ultimate Fighter" has worked hard to regain his footing, and promised not to relapse in spite of a disappointing loss to Andrew Craig over Fourth of July Weekend. UFC President Dana White said he has yet to make a decision on the struggling mixed martial arts (MMA) fighter.
But at least he's on the right path.
For more UFC 162 results, recaps, videos, reactions and other post-fight fallout, check out our "Silva vs. Weidman" wrap-up and link dump by clicking here.